Lawngtlai 26.July,2021 : Naupangte Covid-19 laka an invenna (vaccine) atan Bharat Biotech siam Covaxin chu naupangteah enchhin (trial) mek a ni a, a result chu September 2021-ah chuan tihchhuah beisei a ni tih sawiin All India Institute of Medical Sciences Director Randeep Guleria September thlaah chuan naupangte tan Covid-19 laka invenna vaccine pawh neih a ni dawn a ni a ti. Kum 18-45 inkarte hnena vaccine pek chak taka kalpui angin naupangte hnenah school a\angin a inchhawk (graded manner)-in pek a ni a, naupangte ber an him tawh chuan mipui chuan him nia inhriatna an nei zual (more confident) dawn a ni a ti.
Naupangtea Covaxin enchhinna (trial) chu naupangte an kum azira lahrang in neih a ni a, kum 12-18-ahte neih a ni a, kum 6-12- ah neih a ni leh a, tunah kum 2-6-ah neih leh mek a ni AIIMS Director chuan a ti.
Naupangtea vaccine pek turah chuan Zydus Cadila siam, ZyCov-D tun hnaia India rama hman dil pawh hisap tel a ni a, Zydus Cadila chuan an vaccine chu naupang kum 12-18ah chuan an enchhin zo tawh a ni.
Post a Comment